Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-17.16	45.15	54.51
Graham Fair Price	42.59	6.01	4.21
PEG	-60.21	0.47	-1.17
Price/Book	-7.43	19.48	21.04
Price/Cash Flow	4.31	93.67	89.80
Prices/Earnings	-32.44	30.04	44.46
Price/Sales	23.59	12.66	10.24
Price/FCF	4.31	93.67	89.80
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.23	0.97	0.97
Operating Margin	-8.34	0.18	0.19
ROA	59.83	0.03	0.02
ROE	0.12	0.16	37.03
ROIC	0.04	0.05	7.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.27	0.29	-7.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.55	-0.17	-69.84
EPS QOQ	-0.38	0.65	69.78
FCF QOQ	-0.51	0.08	-84.63
Revenue QOQ	0.29	-0.09	-68.73
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14.52	16.94	16.71
Days Sales Outstanding (DSO)	51.14	56.52	10.52
Inventory Turnover	6.20	5.31	-14.31
Debt/Capitalization	0.84	0.75	-9.81
Quick Ratio	0.93	0.95	2.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.58	3.15	21.81
Cash	1.13	1.45	27.69
Capex	-0.62	-0.49	21.26
Free Cash Flow	0.61	0.65	8.10
Revenue	5.31	4.84	-8.76
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.94	1.00	7.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.96	5.38	-45.96
Naive Interpretation	Member

06 - Financial Health · Bad

Rating